Compile Data Set for Download or QSAR
Found 98 with Last Name = 'trübel' and Initial = 'h'
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190298(US9180120, 2)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190302(US9180120, 6)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)copy SMILES
Affinity DataIC50: 1.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)copy SMILES
Affinity DataIC50: 1.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)copy SMILEScopy InChI
Affinity DataIC50: 2nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190348(US9180120, 52)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190343(US9180120, 47)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190338(US9180120, 42)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)copy SMILEScopy InChI
Affinity DataIC50: 3.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190309(US9180120, 13)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)copy SMILEScopy InChI
Affinity DataIC50: 4nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190349(US9180120, 53)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)copy SMILEScopy InChI
Affinity DataIC50: 4.20nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192467(US10800746, Example WO 2011/104322 101 | US9187466...)copy SMILEScopy InChI
Affinity DataIC50: 4.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192473(US9187466, 132 | US9687476, 132)copy SMILEScopy InChI
Affinity DataIC50: 4.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190343(US9180120, 47)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190321(US9180120, 25)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190305(US9180120, 9)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192474(US9187466, 135 | US9687476, 135)copy SMILEScopy InChI
Affinity DataIC50: 5.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192468(US10800746, Example WO 2011/104322 110 | US9187466...)copy SMILEScopy InChI
Affinity DataIC50: 6.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)copy SMILES
Affinity DataIC50: 6.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190348(US9180120, 52)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)copy SMILEScopy InChI
Affinity DataIC50: 7.70nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190329(US9180120, 33)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190321(US9180120, 25)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190338(US9180120, 42)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)copy SMILEScopy InChI
Affinity DataIC50: 8.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)copy SMILEScopy InChI
Affinity DataIC50: 8.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192453(US10800746, Example WO 2011/104322 54 | US9187466,...)copy SMILES
Affinity DataIC50: 8.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)copy SMILEScopy InChI
Affinity DataIC50: 8.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190306(US9180120, 10)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190353(US9180120, 57)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190335(US9180120, 39)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)copy SMILEScopy InChI
Affinity DataIC50: 11nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190315(US9180120, 19)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192454(US10800746, Example WO 2011/104322 60 | US9187466,...)copy SMILEScopy InChI
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192455(US10800746, Example WO 2011/104322 68 | US9187466,...)copy SMILEScopy InChI
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192463(US9187466, 87 | US9687476, 87)copy SMILEScopy InChI
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190302(US9180120, 6)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190315(US9180120, 19)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190332(US9180120, 36)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)copy SMILEScopy InChI
Affinity DataIC50: 13nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190355(US9180120, 59)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190349(US9180120, 53)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190298(US9180120, 2)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190329(US9180120, 33)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)copy SMILEScopy InChI
Affinity DataIC50: 17nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190363(US9180120, 67)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM190332(US9180120, 36)copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KK99KHUS Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property GmbH

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)copy SMILES
Affinity DataIC50: 19nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2ZG6QDGUS Patent
Displayed 1 to 50 (of 98 total ) | Next | Last >>
Jump to: